Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1974 Oct;30(4):305–311. doi: 10.1038/bjc.1974.197

Protection of Mice Against Syngeneic Lymphomata

II. Collaboration Between Drugs and Antibodies

D A L Davies, S Buckham, A J Manstone
PMCID: PMC2009299  PMID: 4217194

Abstract

Rabbit anti-mouse tumour cell serum can be made tumour specific by absorption with normal mouse cells and in an in vivo protection test can be shown to have a measurable protective effect on mice against a given number of lethal doses of a lymphoma. Some drugs have been evaluated in this system. When drug treatment is combined with antibody treatment much greater protection can be obtained than when the same amounts of drug or antibody are used alone. It is preferable to administer drug before antibody and with the combined schedule it is possible in the test model to protect all mice from tumour growth, even allowing the tumour up to 48 h “get-away” time before starting treatment.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai K., Wallace H. W., Blakemore W. S. Immunotherapy of cancer with L-phenylalanine mustard as a hapten. Cancer Res. 1973 Aug;33(8):1914–1920. [PubMed] [Google Scholar]
  2. BOYLE W., DAVIES D. A., HAUGHTON G. MOUSE TISSUE CELL ANTIGENS. SOME PROPERTIES OF CELL-BOUND COMPONENTS. Immunology. 1963 Sep;6:499–510. [PMC free article] [PubMed] [Google Scholar]
  3. DAVIES D. A. OCCURRENCE OF X ANTIGENIC SPECIFICITY IN HISTOCOMPATIBILITY ANTIGENS PREPARED FROM MOUSE LEUKAEMIC CELLS. Br J Exp Pathol. 1963 Oct;44:546–550. [PMC free article] [PubMed] [Google Scholar]
  4. Davies D. A., Manstone A. J., Buckham S. Protection of mice against syngeneic lymphomata: I. Use of antibodies. Br J Cancer. 1974 Oct;30(4):297–304. doi: 10.1038/bjc.1974.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GORER P. A., AMOS D. B. Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum. Cancer Res. 1956 May;16(4):338–343. [PubMed] [Google Scholar]
  6. Ghose T., Norvell S. T., Guclu A., Cameron D., Bodurtha A., MacDonald A. S. Immunochemotherapy of cancer with chlorambucil-carrying antibody. Br Med J. 1972 Aug 26;3(5825):495–499. doi: 10.1136/bmj.3.5825.495. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES